Insiders · Profile

Dethlefs Sven

EVP, North America Commercial at TEVA PHARMACEUTICAL INDUSTRIES. Filing since 12 Mar 2018. CIK 0001726010

Company
Date
Role
Action
Shares
Amount
Of holding
7 Mar 2023
EVP, North America Commercial
Sold, plan not stated
58,066
$547.44K
26.0%
6 Mar 2023
EVP, North America Commercial
Sold, plan not stated
19,355
$192.21K
8.0%
28 Feb 2023
EVP, North America Commercial
Sold, plan not stated
59,655
$589.79K
26.5%
7 Mar 2022
EVP, North America Commercial
Sold, plan not stated
6,993
$51.52K
4.1%
4 Mar 2022
EVP, North America Commercial
Sold, plan not stated
3,904
$29.21K
2.6%
28 Feb 2022
EVP, North America Commercial
Sold, plan not stated
4,862
$39.59K
4.7%
9 Feb 2022
EVP, North America Commercial
Sold, plan not stated
4,138
$37.49K
4.5%
4 Mar 2021
EVP Global Marketing&Portfolio
Sold, plan not stated
6,012
$63.52K
7.2%
3 Mar 2021
EVP Global Marketing&Portfolio
Sold, plan not stated
606
$6.58K
0.9%
1 Mar 2021
EVP Global Marketing&Portfolio
Sold, plan not stated
7,486
$81.08K
9.8%
9 Feb 2021
EVP Global Marketing&Portfolio
Sold, plan not stated
29,657
$376.48K
33.3%
10 Feb 2020
EVP Global Marketing&Portfolio
Sold, plan not stated
5,669
$69.56K
23.9%
18 Mar 2019
EVP Global Marketing&Portfolio
Sold, plan not stated
632
$10.51K
6.5%
12 Mar 2019
EVP Global Marketing&Portfolio
Sold, plan not stated
647
$10.14K
7.0%
4 Mar 2019
EVP Global Marketing&Portfolio
Sold, plan not stated
606
$10.23K
7.0%
18 Sep 2018
EVP Global Marketing&Portfolio
Sold, plan not stated
625
$14.82K
7.9%
3 Aug 2018
EVP Global Marketing&Portfolio
Bought
2,000
$43.84K
45.0%
19 Mar 2018
EVP Global Marketing&Portfolio
Sold, plan not stated
571
$10.21K
11.4%
12 Mar 2018
EVP Global Marketing&Portfolio
Sold, plan not stated
576
$11.23K
13.1%
19 decisions on file.